Citation: Yaqi Li, Yixin Sun, Qinglong Yan, Wenjing Wang, Shuo Wang, Qing Wang, Danping Wang, Jun Yuan, Jin Sun, Zhonggui He, Zhenbao Li, Bingjun Sun. Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel[J]. Chinese Chemical Letters, ;2026, 37(5): 111350. doi: 10.1016/j.cclet.2025.111350 shu

Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel

Yaqi Li ^{a, 1} ,
Yixin Sun ^{a, 1} ,
Qinglong Yan ^a ,
Wenjing Wang ^a ,
Shuo Wang ^a ,
Qing Wang ^a ,
Danping Wang ^a ,
Jun Yuan ^a ,
Jin Sun ^{a, c} ,
Zhonggui He ^{a, c} ,
Zhenbao Li ^{b, *,} ,
Bingjun Sun ^{a, c, *,}

a.
Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
b.
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
c.
Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China

lizhenbao@ahtcm.edu.cn

sunbingjun_spy@sina.com

Received Date: 26 February 2025
Revised Date: 17 May 2025
Accepted Date: 19 May 2025
Available Online: 20 May 2025

Figures(4)

The advent of the most representative commercially available formulations of paclitaxel, Taxol and Abraxane^®, resolved the intravenous challenge of paclitaxel by increasing the water solubility. However, the severe excipient-related toxicity and poor stability of Taxol, along with the low drug loading (10%), complex preparation processes, and poor tumor selectivity of Abraxane^®, present significant clinical dilemma. To overcome the challenges, 16-methylheptadecanoic acid (16-MH), with excellent biocompatibility was selected as the assembly module. The paclitaxel-16-MH prodrug nanoassemblies (PSSMH NPs) were constructed by conjugating 16-MH with redox-sensitive disulfide bonds and paclitaxel through an ethylene glycol. PSSMH NPs featured the advantages of easy preparation, high drug loading (> 50%) and superior stability (stable storage for 60 days at 25 ℃). Notably, the area under the concentration−time curve (AUC_{0–24 h}) of PSSMH NPs was 14.95-fold compared with Taxol, indicating a significant improvement in the in vivo fate of paclitaxel. Moreover, the existence of redox-sensitive disulfide bonds endowed PSSMH NPs with increased tumor selectivity, resulting in exceptional tolerance and antitumor efficacy. Overall, the redox-triggered prodrug nano-system with high tumor selectivity and biocompatibility exhibits substantial potential for clinical translation.
- Prodrug nanoassemblies,
- Paclitaxel,
- Redox-triggered,
- Tumor selectivity,
- Biocompatibility,
- 16-Methylheptadecanoic acid
1. [1]
  M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, A.T. McPhail, J. Am. Chem. Soc. 93 (1971) 2325–2327. doi: 10.1021/ja00738a045
2. [2]
  T. Konno, J. Watanabe, K. Ishihara, J. Biomed. Mater. Res. 65A (2003) 209–214. doi: 10.1002/jbm.a.10481
3. [3]
  Q. Song, Y. Yin, L. Shang, et al., Nano Lett. 17 (2017) 6366–6375. doi: 10.1021/acs.nanolett.7b03186
4. [4]
  S. Benizri, L. Ferey, B. Alies, et al., Nanoscale Res. Lett. 13 (2018) 17. doi: 10.1186/s11671-017-2420-2
5. [5]
  Q. Xu, L.A. Trissel, J.F. Martinez, Am. J. Hosp. Pharm. 51 (1994) 3058–3060. doi: 10.1093/ajhp/51.24.3058
6. [6]
  B. Pourroy, C. Botta, C. Solas, B. Lacarelle, D. Braguer, J. Clin. Pharm. Ther. 30 (2005) 455–458. doi: 10.1111/j.1365-2710.2005.00669.x
7. [7]
  B. Rodrigues Arruda, M.G.A. Mendes, P.G.C. de Freitas, et al., J. Drug Deliv. Sci. Technol. 80 (2023) 104070. doi: 10.1016/j.jddst.2022.104070
8. [8]
  Q. Chen, S. Xu, S. Liu, Y. Wang, G. Liu, J. Control. Release 342 (2022) 280–294. doi: 10.1016/j.jconrel.2022.01.010
9. [9]
  H. Linxweiler, J. Thiesen, I. Krämer, Pharmaceutics 16 (2024) 1372. doi: 10.3390/pharmaceutics16111372
10. [10]
  Q. Pei, B. Jiang, D. Hao, Z. Xie, Acta Pharm. Sin. B 13 (2023) 3252–3276. doi: 10.1016/j.apsb.2023.02.021
11. [11]
  X. Wu, X. Chen, X. Wang, H. He, J. Chen, W. Wu, Chin. Chem. Lett. 35 (2024) 108756. doi: 10.1016/j.cclet.2023.108756
12. [12]
  W. Zhang, X. Deng, L. Wang, et al., Chin. Chem. Lett. 35 (2024) 109422. doi: 10.1016/j.cclet.2023.109422
13. [13]
  T. Tong, L. Chen, S. Wu, et al., Chin. Chem. Lett. 35 (2024) 109689. doi: 10.1016/j.cclet.2024.109689
14. [14]
  W. Zang, Y. Sun, J. Zhang, et al., Chin. Chem. Lett. 36 (2025) 110230. doi: 10.1016/j.cclet.2024.110230
15. [15]
  Y. Meng, J. Wu, Chin. J. Polym. Sci. 40 (2022) 1016–1027. doi: 10.1007/s10118-022-2701-9
16. [16]
  J. Wang, L. Wang, S. Li, et al., Nanoscale 12 (2020) 15767–15774. doi: 10.1039/d0nr03138k
17. [17]
  M. Kyu Shim, S. Yang, I.C. Sun, K. Kim, Adv. Drug Deliv. Rev. 183 (2022) 114177. doi: 10.1016/j.addr.2022.114177
18. [18]
  L. Li, T. Liu, S. Zuo, et al., Adv. Mater. 36 (2024) 2310633. doi: 10.1002/adma.202310633
19. [19]
  S. Zuo, T. Liu, L. Li, et al., Cell Rep. Med. 5 (2024) 101432. doi: 10.1016/j.xcrm.2024.101432
20. [20]
  B. Zhang, W. Liu, J. Liu, et al., Fundam. Res. (2024), doi: 10.1016/j.fmre.2024.06.006. doi: 10.1016/j.fmre.2024.06.006
21. [21]
  L. Li, S. Zuo, F. Dong, et al., Asian J. Pharm. Sci. 16 (2021) 337–349.
22. [22]
  T. Liu, L. Li, S. Wang, et al., Nat. Commun. 13 (2022) 7228. doi: 10.1038/s41467-022-35033-7
23. [23]
  G. Li, B. Sun, Y. Li, et al., Small 17 (2021) e2101460. doi: 10.1002/smll.202101460
24. [24]
  S. Wang, T. Liu, Y. Huang, et al., Acta Pharm. Sin. B 14 (2024) 1400–1411. doi: 10.1016/j.apsb.2023.09.017
25. [25]
  Y. Yang, W. Zeng, P. Huang, X. Zeng, L. Mei, VIEW 2 (2021) 20200042. doi: 10.1002/VIW.20200042
26. [26]
  X. Xue, H. Qu, Y. Li, Exploration 2 (2022) 20210134. doi: 10.1002/EXP.20210134
27. [27]
  J. Peiró Cadahía, V. Previtali, N.S. Troelsen, M.H. Clausen, Medchemcomm 10 (2019) 1531–1549. doi: 10.1039/c9md00169g
28. [28]
  Y. Chu, Y. Luo, B. Su, et al., Acta Pharm. Sin. B 13 (2023) 298–314. doi: 10.1016/j.apsb.2022.05.027
29. [29]
  B. Sun, C. Luo, H. Yu, et al., Nano Lett. 18 (2018) 3643–3650. doi: 10.1021/acs.nanolett.8b00737
30. [30]
  Q. Wang, M. Serda, Q. Li, T. Sun, Adv. Healthc. Mater. 12 (2023) e2300138. doi: 10.1002/adhm.202300138
31. [31]
  B. Sun, C. Luo, X. Zhang, et al., Nat. Commun. 10 (2019) 3211. doi: 10.1038/s41467-019-11193-x
32. [32]
  A.P. Garg, J. Müller, Mycoses 36 (1993) 51–63. doi: 10.1111/j.1439-0507.1993.tb00687.x
33. [33]
  Y. Yang, X. Li, J. Song, et al., Nano Lett. 23 (2023) 1530–1538. doi: 10.1021/acs.nanolett.2c04976
34. [34]
  Y. Sun, S. Wang, J. Liu, et al., Nano Today 56 (2024) 102275. doi: 10.1016/j.nantod.2024.102275
35. [35]
  Y. Li, Y. Sun, Q. Wang, et al., ACS Cent. Sci. (2024) 2253–2265.
36. [36]
  N. Fattahi, M.A. Shahbazi, A. Maleki, et al., J. Control. Release 326 (2020) 556–598. doi: 10.1016/j.jconrel.2020.07.012
37. [37]
  X. Su, F. Magkos, D. Zhou, et al., Obes. Silver Spring Md. 23 (2015) 329–334. doi: 10.1002/oby.20923
38. [38]
  J.I. Martínez-Montoro, M. Á. Núñez-Sánchez, M.A. Martinez-Sanchez, et al., Obesity 31 (2023) 1064–1074. doi: 10.1002/oby.23711
39. [39]
  P. Gozdzik, F. Magkos, T. Sledzinski, A. Mika, Prog. Lipid Res. 90 (2023) 101226. doi: 10.1016/j.plipres.2023.101226
40. [40]
  A.K. Singla, A. Garg, D. Aggarwal, Int. J. Pharm. 235 (2002) 179–192. doi: 10.1016/S0378-5173(01)00986-3
41. [41]
  M. Dellian, F. Yuan, V.S. Trubetskoy, V.P. Torchilin, R.K. Jain, Br. J. Cancer 82 (2000) 1513–1518. doi: 10.1054/bjoc.1999.1171
42. [42]
  S.D. Perrault, C. Walkey, T. Jennings, H.C. Fischer, W.C.W. Chan, Nano Lett. 9 (2009) 1909–1915. doi: 10.1021/nl900031y
43. [43]
  Z. Wang, L. Ling, Y. Du, C. Yao, X. Li, Int. J. Pharm. 564 (2019) 244–255. doi: 10.1016/j.ijpharm.2019.04.060
44. [44]
  X. Zhang, F. Zhao, J. Feng, et al., Mol. Pharm. 20 (2023) 2642–2649. doi: 10.1021/acs.molpharmaceut.3c00079
45. [45]
  H. Liang, X. Ren, J. Qian, et al., ACS Appl. Mater. Interfaces 8 (2016) 10136–10146. doi: 10.1021/acsami.6b00668
1. [1]
  Wenfeng Zang , Yixin Sun , Jingyi Zhang , Yanzhong Hao , Qianhui Jin , Hongying Xiao , Zuo Zhang , Xianbao Shi , Jin Sun , Zhonggui He , Cong Luo , Bingjun Sun . Two-tailed modification module tuned steric-hindrance effect enabling high therapeutic efficacy of paclitaxel prodrug nanoassemblies. Chinese Chemical Letters, 2025, 36(5): 110230-. doi: 10.1016/j.cclet.2024.110230
2. [2]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
3. [3]
  Chao Liu , Liming Gong , Yanhong Liu , Shuangqing Wang , Hao Wu , Liqing Chen , Mingji Jin , Zhonggao Gao , Wei Huang . Lipoic acid-locked reduction-responsive core-cross-linked micelles delivering paclitaxel for triple-negative breast cancer treatment. Chinese Chemical Letters, 2025, 36(8): 110570-. doi: 10.1016/j.cclet.2024.110570
4. [4]
  Xiaomeng Hu , Jie Yu , Lijie Sun , Linfeng Zhang , Wei Zhou , Dongpeng Yan , Xinrui Wang . Synthesis of an AVB@ZnTi-LDH composite with synergistically enhance UV blocking activity and high stability for potential application in sunscreen formulations. Chinese Chemical Letters, 2024, 35(11): 109466-. doi: 10.1016/j.cclet.2023.109466
5. [5]
  Guoyin Chen , Siming Xu , Zeqi Zhang , Ying Guo , Jiahao Zheng , Jialei Yang , Jie Pan , Kai Hou , Meifang Zhu . Modulus self-adaptive hydrogel optical fiber for long-term modulation of neural activity. Chinese Chemical Letters, 2025, 36(7): 110440-. doi: 10.1016/j.cclet.2024.110440
6. [6]
  Xinwei Hu , Yong Zeng , Jiongdong Ma , Han Diao , Fei-Xiao Chen , Mu Chen , Shou-Kun Zhang , Chengzhi Jin , Shao-Fei Ni , Zhixiong Ruan . Electrochemical selenylation of tyrosine oligopeptides to benzo[b]furan-functionalized peptides. Chinese Chemical Letters, 2026, 37(3): 111928-. doi: 10.1016/j.cclet.2025.111928
7. [7]
  Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227
8. [8]
  Yixin Sun , Keke Yu , Xiuchun Guo , Lanlan Zong , Zhonggui He , Xiaohui Pu . Three-in-one reduction and acid-ignited micelles amplify antitumor efficacy via precise synergistic delivery of paclitaxel and naringenin. Chinese Chemical Letters, 2025, 36(6): 110393-. doi: 10.1016/j.cclet.2024.110393
9. [9]
  Yupeng Wang , Xinxin Sun , Jianbin Shi , Zhixiao Zhang , Jin Sun , Cong Luo , Zhonggui He , Shenwu Zhang . Chain architecture-engineered artesunate nanoassemblies target LONP1 to induce oxidative damage for enhanced anti-tumor therapy. Chinese Chemical Letters, 2026, 37(1): 111609-. doi: 10.1016/j.cclet.2025.111609
10. [10]
  Zhihui Zhang , Ru Sun , Chong Bian , Hongbo Wang , Zhen Zhao , Panpan Lv , Jianzhong Lu , Haixin Zhang , Hulie Zeng , Yuanyuan Chen , Zhijuan Cao . A dual-protease-triggered chemiluminescent probe for precise tumor imaging. Chinese Chemical Letters, 2025, 36(2): 109784-. doi: 10.1016/j.cclet.2024.109784
11. [11]
  Xiaopeng Han , Jiayin Li , Fei Li , Zhongyue Yuan , Hao Li , Lei Yang , Yan-Ming Xia , Chao Teng , Chao Qin , Lifang Yin . ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade. Chinese Chemical Letters, 2026, 37(2): 111335-. doi: 10.1016/j.cclet.2025.111335
12. [12]
  Ji Liu , Dongsheng He , Tianjiao Hao , Yumin Hu , Yan Zhao , Zhen Li , Chang Liu , Daquan Chen , Qiyue Wang , Xiaofei Xin , Yan Shen . Gold mineralized "hybrid nanozyme bomb" for NIR-II triggered tumor effective permeation and cocktail therapy. Chinese Chemical Letters, 2024, 35(9): 109296-. doi: 10.1016/j.cclet.2023.109296
13. [13]
  Yingtao Zhong , Ziwen Qiu , Yanmei Li , Jiaqi Huang , Zhenming Lu , Renjiang Kong , Ni Yan , Hong Cheng . Nutrients deprivation of biomimetic nanozymes for cascade catalysis triggered and oxidative damage induced tumor eradication. Chinese Chemical Letters, 2025, 36(3): 109846-. doi: 10.1016/j.cclet.2024.109846
14. [14]
  Yuan Xiong , Lan-Hui Qin , Bei Zhao , Lei-Zhi Xu , Yu-Fan Fan , Tian Tian , Hai-Rong Zeng , Ting Liu , Jian Huang , Jian-Ming Sun , Zhen-Hao Tian , Guang-Bo Ge . Structure-based design and development of halogenated-naphthalimides as potent hCYP1B1 inhibitors for overcoming paclitaxel resistance. Chinese Chemical Letters, 2025, 36(11): 110812-. doi: 10.1016/j.cclet.2024.110812
15. [15]
  Huipeng Zhao , Xiaoqiang Du . Polyoxometalates as the redox anolyte for efficient conversion of biomass to formic acid. Chinese Journal of Structural Chemistry, 2024, 43(2): 100246-100246. doi: 10.1016/j.cjsc.2024.100246
16. [16]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
17. [17]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
18. [18]
  Jin-Ao Li , Nana Pan , Li Lu , Yifan Wei , Wenchang Hu , Zhiyang Zhang , Houda Amrani , Fang Huang , Xiaojuan Wang . Ligand-bridged nanoassemblies boost the peroxidase-mimicking activity of gold nanoclusters. Chinese Chemical Letters, 2026, 37(1): 111806-. doi: 10.1016/j.cclet.2025.111806
19. [19]
  Qijun Tang , Wenguang Tu , Yong Zhou , Zhigang Zou . High efficiency and selectivity catalyst for photocatalytic oxidative coupling of methane. Chinese Journal of Structural Chemistry, 2023, 42(12): 100170-100170. doi: 10.1016/j.cjsc.2023.100170
20. [20]
  Rui HUANG , Shengjie LIU , Qingyuan WU , Nanfeng ZHENG . Enhanced selectivity of catalytic hydrogenation of halogenated nitroaromatics by interfacial effects. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 201-212. doi: 10.11862/CJIC.20240356

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(6)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142